T1	Participants 74 118	autosomal dominant polycystic kidney disease
T2	Participants 131 183	Autosomal dominant polycystic kidney disease (ADPKD)
T3	Participants 575 594	patients with ADPKD
T4	Participants 596 651	Sixty patients were initially recruited but 49 of these
